High serum matrix metalloproteinase-9 level predict increased risk of in-hospital cardiac events in patients with type 2 diabetes and ST segment elevation myocardial infarction-Reference-Cited by-同舟云学术

High serum matrix metalloproteinase-9 level predict increased risk of in-hospital cardiac events in patients with type 2 diabetes and ST segment elevation myocardial infarction

Published:2008-01 Issue:1 Volume:196 Page:365-371
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Dominguez-Rodriguez Alberto,Abreu-Gonzalez Pedro,Garcia-Gonzalez Martín J.,Kaski Juan Carlos

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Emerging role of metalloproteinases in the pathophysiology of cardiac diseases;Diez;Eur J Clin Invest,2002

2. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart;Cheung;Circulation,2000

3. Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion;Lindsey;Circulation,2001

4. Peripheral blood levels of matrix metalloproteases-2 and −9 are elevated in patients with acute coronary syndromes;Kai;J Am Coll Cardiol,1998

5. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome;Inokubo;Am Heart J,2001

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Matrix metallopeptidase 9 and outcome prediction in patients with acute coronary syndrome;Pathologia;2022-08-22

2. Early Treatment of Acute Myocardial Infarction with Melatonin: Effects on MMP-9 and Adverse Cardiac Events;Journal of Clinical Medicine;2022-03-30

3. Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis – Diabetes co-morbidity;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2021-05

4. Metalloproteinases as a prognostic marker in ST-elevation myocardial infarction;Revista Portuguesa de Cardiologia;2020-05

5. Metalloproteinases as a prognostic marker in ST-elevation myocardial infarction;Revista Portuguesa de Cardiologia (English Edition);2020-05